BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 9
• 10
• 11
• 12
• 13
• 15
• 16
• 17
• 18
• 19
• 20
• 22
• 23
• 24
• 25
• 26
• 27
• 30
• 31

• Press Releases

  Alpha Cognition to Present New Clinical on ZUNVEYL® (Benzgalantamine) at Multiple Upcoming Alzheimer’s Association International Conferences

  March 10, 2026

   · 

  8 min read
• Press Releases

  VB Spine Announces Successful First Clinical Cases of Vulcan™ Spinal System

  March 10, 2026

   · 

  2 min read
• Press Releases

  GeneDx to Launch Genetic Testing Program with Zevra Therapeutics to Support Patients with Suspected Niemann-Pick Disease Type C

  March 10, 2026

   · 

  5 min read
• Press Releases

  Trialbee Appoints Accomplished Life Sciences Executive Rick Riegel to Board of Directors to Accelerate Global Patient Recruitment for Clinical Trials

  March 10, 2026

   · 

  3 min read
• Press Releases

  Odyssey Therapeutics Appoints H. Martin Seidel, Ph.D., to Scientific Advisory Board

  March 10, 2026

   · 

  3 min read
• Press Releases

  NEXGEL Signs Definitive Agreement to License and Acquire Transformative Portfolio of Commercial-Stage Regenerative Biomaterial Products

  March 10, 2026

   · 

  6 min read
• Press Releases

  Propanc Biopharma Executes Service Agreement with FyoniBio to Establish & Validate Pharmacokinetics Assay for Phase 1b First-In-Human Study

  March 10, 2026

   · 

  4 min read
• Press Releases

  Oragenics Receives HREC Approval for Phase IIa Clinical Trial of ONP-002 as a Treatment for Concussion and Mild Traumatic Brain Injury in Australia

  March 10, 2026

   · 

  7 min read
• Press Releases

  Hoth Therapeutics Reports Positive Female Preclinical Data Showing HT-VA Restores Cholesterol Levels and Improves Lipid Metabolism in MASLD Model

  March 10, 2026

   · 

  6 min read
• Press Releases

  Celularity Secures $35 Million Strategic License Deal, Strengthens Capital Position to Advance Longevity-Focused Strategy

  March 10, 2026

   · 

  6 min read